Literature DB >> 16705573

Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum.

Jonathan D Kurtis1, Jennifer F Friedman, Tjalling Leenstra, Gretchen C Langdon, Hai-Wei Wu, Daria L Manalo, Li Su, Mario Jiz, Blanca Jarilla, Archie O Pablo, Stephen T McGarvey, Remigio M Olveda, Luz P Acosta.   

Abstract

BACKGROUND: In communities where Schistosoma species are endemic, the prevalence and intensity of schistosomiasis is disproportionately high among children, compared with adults. This epidemiologic pattern is consistent with either the slow development of resistance or the requirement of host developmental changes for the expression of resistance.
METHODS: We enrolled 87 individuals aged 7-18 years who did not have Schistosoma japonicum infection and 641 individuals aged 7-30 years with S. japonicum infection, all of whom reside in 3 villages in Leyte, Philippines. At baseline, S. japonicum infection was assessed by Kato-Katz thick-smear stool examination, and the levels of the pubertal hormone dehydroepiandrosterone sulfate (DHEA-S) in serum were determined. Individuals with S. japonicum infection were treated with praziquantel, after which stool examination and DHEA-S level measurement were performed every 3 months for 18 months.
RESULTS: In cross-sectional analyses, the intensity of infection among individuals with high DHEA-S levels was 43% lower (28 eggs per g, n = 243), compared with individuals with low DHEA-S levels (50 eggs per g, n = 242), even after adjusting for age, sex, and village (P = .01). Following praziquantel treatment, increased DHEA-S levels were associated with resistance to reinfection (P = .006). The intensity of reinfection among individuals with high DHEA-S levels was 42% lower, compared with individuals with low DHEA-S levels, even after adjusting for age, baseline intensity of S. japonicum infection, village, sex and water contact (P < .001).
CONCLUSIONS: Increased DHEA-S levels in serum, a marker for adrenal development, is associated with reduced S. japonicum infection and reinfection, even after adjusting for age and, by proxy, cumulative exposure. These data suggest that an intrinsic property of host pubertal development mediates, in part, the resistance to infection observed in older individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705573     DOI: 10.1086/504326

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasis.

Authors:  David Gurarie; Xiaoxia Wang; Amaya L Bustinduy; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

2.  Geographical distribution of human Schistosoma japonicum infection in The Philippines: tools to support disease control and further elimination.

Authors:  Ricardo J Soares Magalhães; Maria Sonia Salamat; Lydia Leonardo; Darren J Gray; Hélène Carabin; Kate Halton; Donald P McManus; Gail M Williams; Pilarita Rivera; Ofelia Saniel; Leda Hernandez; Laith Yakob; Stephen McGarvey; Archie Clements
Journal:  Int J Parasitol       Date:  2014-08-13       Impact factor: 3.981

3.  Age-Stratified Profiles of Serum IL-6, IL-10, and TNF-α Cytokines Among Kenyan Children with Schistosoma haematobium, Plasmodium falciparum, and Other Chronic Parasitic Co-Infections.

Authors:  Amaya L Bustinduy; Laura J Sutherland; Alicia Chang-Cojulun; Indu Malhotra; Adam S DuVall; Jessica K Fairley; Peter L Mungai; Eric M Muchiri; Francis M Mutuku; Uriel Kitron; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2015-03-09       Impact factor: 2.345

Review 4.  Schistosomiasis vaccines.

Authors:  Afzal A Siddiqui; Bilal A Siddiqui; Lisa Ganley-Leal
Journal:  Hum Vaccin       Date:  2011-11-01

5.  Neglected tropical diseases outside the tropics.

Authors:  Francesca F Norman; Ana Pérez de Ayala; José-Antonio Pérez-Molina; Begoña Monge-Maillo; Pilar Zamarrón; Rogelio López-Vélez
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

Review 6.  Pediatric multiple sclerosis.

Authors:  Dorothee Chabas; Jonathan Strober; Emmanuelle Waubant
Journal:  Curr Neurol Neurosci Rep       Date:  2008-09       Impact factor: 5.081

7.  Whole-Proteome Differential Screening Identifies Novel Vaccine Candidates for Schistosomiasis japonica.

Authors:  Hannah W Wu; Sangshin Park; Sunthorn Pond-Tor; Ron Stuart; Sha Zhou; Yang Hong; Amanda E Ruiz; Luz Acosta; Blanca Jarilla; Jennifer F Friedman; Mario Jiz; Jonathan D Kurtis
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

8.  IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni.

Authors:  Mark S Wilson; Allen W Cheever; Sandra D White; Robert W Thompson; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2011-08-04       Impact factor: 6.823

9.  Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality.

Authors:  Martin Walker; Mark P Little; Karen S Wagner; Edoh W Soumbey-Alley; Boakye A Boatin; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

10.  Treatment for Schistosoma japonicum, reduction of intestinal parasite load, and cognitive test score improvements in school-aged children.

Authors:  Amara E Ezeamama; Stephen T McGarvey; Joseph Hogan; Kate L Lapane; David C Bellinger; Luz P Acosta; Tjalling Leenstra; Remigio M Olveda; Jonathan D Kurtis; Jennifer F Friedman
Journal:  PLoS Negl Trop Dis       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.